Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,318 | 2 | -4,973 | -3,429 | -2,266 |
| Depreciation Amortization | 205 | 102 | 400 | 296 | 197 |
| Accounts receivable | -285 | -512 | 209 | -327 | -387 |
| Other Working Capital | -429 | -550 | 260 | -361 | -308 |
| Other Operating Activity | 568 | 690 | 263 | 641 | 629 |
| Operating Cash Flow | $-1,259 | $-268 | $-3,841 | $-3,180 | $-2,135 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | -37 | -37 | -33 |
| Other Investing Activity | 0 | 0 | -37 | -37 | -33 |
| Investing Cash Flow | $N/A | $N/A | $-37 | $-37 | $-33 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,432 | 939 | 2,158 | 2,159 | 392 |
| Other Financing Activity | -30 | -19 | -47 | -43 | -12 |
| Financing Cash Flow | $1,402 | $920 | $2,111 | $2,116 | $380 |
| Exchange Rate Effect | 1 | 2 | -3 | -11 | -10 |
| Beginning Cash Position | 2,399 | 2,399 | 4,170 | 4,170 | 4,170 |
| End Cash Position | 2,543 | 3,053 | 2,400 | 3,058 | 2,372 |
| Net Cash Flow | $144 | $654 | $-1,770 | $-1,112 | $-1,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,259 | -268 | -3,841 | -3,180 | -2,135 |
| Free Cash Flow | -1,259 | -268 | -3,841 | -3,180 | -2,135 |